Variation in HDL cholesterol methodology and calibration may lead to erroneous cardiovascular risk estimation

被引：0
|
作者：
Delanghe, J. R. [1 ]
De Buyzere, M. L. [1 ]
Rietzschel, E. [2 ]
De Backer, G. [2 ]
De Bacquer, D. [2 ]
机构：
[1] State Univ Ghent Hosp, B-9000 Ghent, Belgium
[2] Univ Ghent, B-9000 Ghent, Belgium
来源：
CLINICAL CHEMISTRY | 2008年 / 54卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
D6
引用
收藏
页码：A146 / A146
页数：1
相关论文
共 50 条
  • [31] Association between FTO gene polymorphisms and HDL cholesterol concentration may cause higher risk of cardiovascular disease in patients with acromegaly
    Aleksandra Franczak
    Katarzyna Kolačkov
    Aleksandra Jawiarczyk-Przybyłowska
    Marek Bolanowski
    Pituitary, 2018, 21 : 10 - 15
  • [32] Association between FTO gene polymorphisms and HDL cholesterol concentration may cause higher risk of cardiovascular disease in patients with acromegaly
    Franczak, Aleksandra
    Kolackov, Katarzyna
    Jawiarczyk-Przybylowska, Aleksandra
    Bolanowski, Marek
    PITUITARY, 2018, 21 (01) : 10 - 15
  • [33] HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target
    Anish Bhatt
    Anand Rohatgi
    Current Atherosclerosis Reports, 2016, 18
  • [34] Elevated Non-HDL Cholesterol: cardiovascular Risk from Childhood onwards
    Kessing, Richard
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (04) : 248 - 248
  • [35] Effect of historical changes in HDL-cholesterol measurements on cardiovascular risk assessment
    Marrington, R.
    Webster, C.
    Jewkes, C.
    Jones, A.
    ATHEROSCLEROSIS, 2011, 218 (02) : E2 - E2
  • [36] HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target
    Bhatt, Anish
    Rohatgi, Anand
    CURRENT ATHEROSCLEROSIS REPORTS, 2016, 18 (01) : 1 - 8
  • [37] ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management
    de Nijs, Tjerk
    Sniderman, Allan
    de Graaf, Jacqueline
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2013, 50 (06) : 163 - 171
  • [38] Non-HDL cholesterol contributes to the "hypertriglyceridemic waist" as a cardiovascular risk factor
    Bos, G
    Dekker, JM
    Heine, R
    DIABETES CARE, 2004, 27 (01) : 283 - 284
  • [39] Composition of non-HDL cholesterol and residual cardiovascular risk in secondary prevention
    Hansen, M. K.
    Olesen, K. K. W.
    Thrane, P. G.
    Gyldenkerne, C.
    Stoedkilde-Joergensen, N.
    Andersen, M. H.
    Maeng, M.
    Mortensen, M. B.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [40] A Retrospective Analysis of Non-HDL Cholesterol: For Improved Cardiovascular Risk Assessment
    Khan, Sohail Rafi
    Mukhtar, Ana
    Ahmed, Altaf
    ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE, 2015, 20 (02): : 97 - 102
12345